23948sdkhjf
Log in or create to bookmark articles
Get access to all content on Life Science Focus
No commitment or card information required
Applies to personal subscription only.
Contact us for a enterprise solution.
Advertisement
Advertisement

Miris under pressure as sales fall – CEO steps down

Following a sharp decline in sales, Swedish medtech company Miris is planning a SEK 20 million rights issue. At the same time, long-serving CEO Camilla Myhre Sandberg is stepping down, while the company’s major shareholder is proposing changes to the board.
Advertisement

Miris, which develops analytical instruments for breast milk, announced several changes to the company on Monday evening.

Camilla Myhre Sandberg is stepping down as CEO after ten years and will be temporarily replaced by Marie Ekholm, who has been Head of Sales and Marketing at Miris since 2018. She takes up the role on 27 October and will also retain her current position, while the board begins the search for a permanent successor.

Advertisement Advertisement
BREAKING
{{ article.headline }}
0.063|instance-web01